TianYu Bio-Technology Co., Ltd. (SHA:603717)
China flag China · Delayed Price · Currency is CNY
6.70
+0.16 (2.45%)
Sep 7, 2026, 3:00 PM CST

TianYu Bio-Technology Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-190.38-106.9-107.36-461.64-279.41-214.74
Depreciation & Amortization
65.2859.3764.4564.6543.718.12
Other Amortization
1.991.721.250.990.730.9
Loss (Gain) From Sale of Assets
-0.01-25.970.67-0.99-47.44-8.81
Asset Writedown & Restructuring Costs
24.862.417.9314.9758.571.8
Loss (Gain) From Sale of Investments
-19.97-4.520.21109.7-1.84-17.47
Provision & Write-off of Bad Debts
-3.83-3.8320.412.2247.64170.58
Other Operating Activities
80.4387.1676.8417.493.7846.9
Change in Accounts Receivable
84.1660.73-56.5629.49-290.33-84.1
Change in Inventory
61.61211.8995.2656.1464.42-33.24
Change in Accounts Payable
57.53-26.8830.382.29259.98-80.5
Change in Other Net Operating Assets
---1.350.561.36-
Operating Cash Flow
163.19258.3135.29-175.93105.53-223.32
Operating Cash Flow Growth
-2.39%90.93%----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-32.07-53.48-54.02-84.54-83.34-6.93
Sale of Property, Plant & Equipment
0.240.20.530.03220.0921.63
Cash Acquisitions
-47.31-60.51-15.86-6.94-0.560
Divestitures
---0.992.40.16-
Investment in Securities
-2.12-2.05-0.571.76-209.3364.75
Other Investing Activities
-4.17-7.144.53-9.875.58-
Investing Cash Flow
-85.42-122.96-64.89-102.24-93.6379.45

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
----139.5297.1
Long-Term Debt Issued
-338.07486.88629.11884.28568.05
Total Debt Issued
333.67338.07486.88629.111,024865.15
Short-Term Debt Repaid
-----189.5-272.3
Long-Term Debt Repaid
--416.38-492.61-438.57-798.36-807.14
Lease Payments
-19.41-19.41-20.15-35.22-28.6-41.59
Total Debt Repaid
-410.51-416.38-492.61-438.57-987.86-1,079
Net Debt Issued (Repaid)
-76.84-78.3-5.73190.5335.91-214.29
Issuance of Common Stock
---0.71-396.57
Common Dividends Paid
-47.79-50.06-43.31-43.81-56.32-50.08
Other Financing Activities
15.65-16.36-16.22-15.7873.7173.71
Financing Cash Flow
-108.98-144.72-65.26131.6653.3205.92

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.080.060.09---
Net Cash Flow
-31.29-9.335.23-146.5165.262.05

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
131.12204.8281.27-260.4822.19-230.25
Free Cash Flow Growth
7.33%152.03%----
Free Cash Flow Margin
19.75%28.23%10.14%-38.85%2.35%-36.09%
Free Cash Flow Per Share
0.450.710.28-0.900.09-0.87
Levered Free Cash Flow
-28.59186.55241.67-96.8381.23-304.4
Unlevered Free Cash Flow
4.75219.88264.5-77.7399.47-273.93
Free Cash Flow After Leases
111.71185.4161.11-295.69-6.41-271.84

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
19.8716.3214.1510.4428.7633.96
Change in Working Capital
204.81248.8670.8976.79-10.19-220.59